financetom
Business
financetom
/
Business
/
Illinois Tool Works Q4: Revenue Declines, EPS Tops Estimates, 2025 Outlook Signals Modest Growth & More
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Illinois Tool Works Q4: Revenue Declines, EPS Tops Estimates, 2025 Outlook Signals Modest Growth & More
Feb 5, 2025 7:41 AM

Illinois Tool Works Inc. ( ITW ) reported fourth-quarter revenue of $3.932 billion, a decline of 1.3% year over year and missing the consensus of $3.99 billion.

Organic growth dropped 0.5% in revenue; excluding a 0.9% impact from Product Line Simplification, organic growth was positive at 0.4%.

Revenue By Segments: Automotive OEM $785 million (-4% YoY), Food Equipment $672 million (+3% YoY), Test & Measurement and Electronics $747 million (+2% YoY), Welding $447 million (-1% YoY), Polymers & Fluids $430 million (-2% YoY), Construction Products $438 million (-5% YoY) and Specialty Products $416 million (-5% YoY).

Operating income increased 4.4% year over year to $1.031 billion, and the operating margin expanded 140 bps to 26.2%. EPS for the quarter stood at $2.54, up 7% YoY, and above the consensus of $2.50.

ITW’s operating cash flow reached $1.1 billion, while free cash flow rose 10% to $1.0 billion, with a conversion of 133% to net income. The company repurchased $375 million in shares during the quarter, with an effective tax rate of 23.7%.

“Throughout 2024, the ITW team delivered a year of solid operational and financial performance, achieving record financial results by consistently exceeding market growth and significantly improving profitability and margins. Building on this momentum, we will continue to outperform our key end markets in 2025 as we build above-market organic growth, driven by continuous improvement in Customer-Back Innovation, into a core ITW strength,” commented Christopher A. O’Herlihy, President and Chief Executive Officer.        

2025 Guidance: ITW expects GAAP EPS of $10.15 – $10.55 versus the consensus of $10.62. The company projects above-market organic growth of 0% – 2% based on current levels of demand. The company sees organic growth of 1 to 3% excluding PLS reduction of approximately 1%-point.

Based on current foreign exchange rates, foreign currency translation is expected to reduce revenue by 3%, resulting in a projected total revenue decline of 1% – 3%.

The company’s operating margin is expected between 26.5% and 27.5%, improving by 100 basis points, supported by enterprise initiatives.

Free cash flow is projected to exceed net income, with $1.5 billion in planned share repurchases and an effective tax rate of 24% – 24.5%.

Price Action: ITW shares traded lower by 1.66% at $250.44 at the last check Wednesday.

Image via Shutterstock.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hawkins Insider Bought Shares Worth $288,907, According to a Recent SEC Filing
Hawkins Insider Bought Shares Worth $288,907, According to a Recent SEC Filing
Jun 10, 2024
04:31 PM EDT, 06/10/2024 (MT Newswires) -- James A Faulconbridge, Director, on June 06, 2024, executed a purchase for 3,300 shares in Hawkins (HWKN) for $288,907. Following the Form 4 filing with the SEC, Faulconbridge has control over a total of 42,017 shares of the company, with 42,017 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/46250/000141588924016220/xslF345X03/form4-06102024_080621.xml ...
Eli Lilly exec says seeing out of pocket payments for obesity drug in US
Eli Lilly exec says seeing out of pocket payments for obesity drug in US
Jun 10, 2024
June 10 (Reuters) - A top Eli Lilly ( LLY ) executive said on Monday that more patients are paying the full list price of its obesity drug Zepbound than those who had paid for its predecessor Mounjaro. Patrik Jonsson, President of Lilly Diabetes and Obesity, speaking at a Goldman Sachs healthcare conference, said a mid-single digit percentage of patients...
Energy Recovery Insider Sold Shares Worth $263,950, According to a Recent SEC Filing
Energy Recovery Insider Sold Shares Worth $263,950, According to a Recent SEC Filing
Jun 10, 2024
04:36 PM EDT, 06/10/2024 (MT Newswires) -- Arve Hanstveit, Director, on June 06, 2024, sold 20,000 shares in Energy Recovery ( ERII ) for $263,950. Following the Form 4 filing with the SEC, Hanstveit has control over a total of 883,182 shares of the company, with 763,182 shares held directly and 120,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1421517/000142151724000129/xslF345X03/wk-form4_1718051656.xml ...
Array Technologies CFO Kurt Wood to Step Down on June 30
Array Technologies CFO Kurt Wood to Step Down on June 30
Jun 10, 2024
04:35 PM EDT, 06/10/2024 (MT Newswires) -- Array Technologies ( ARRY ) said late Monday that Kurt Wood will step down as chief financial officer on June 30 to pursue other business interests. Wood will remain with the solar-tracking equipment company as a consultant through the end of September to assist with the transition. The company said it has begun...
Copyright 2023-2026 - www.financetom.com All Rights Reserved